Especially in immuno-oncology, not only the expression of target antigens, but also the tumor mutation burden and the degree of infiltration of immune cells (CD8 + T cells) into the tumor environment may be useful biomarkers29,30. This evidence concerns the gene CD8A and neoplasm.